Adverse neuropsychiatric events and recreational use of efavirenz and other HIV-1 antiretroviral drugs DA Dalwadi, L Ozuna, BH Harvey, M Viljoen, JA Schetz Pharmacological reviews 70 (3), 684-711, 2018 | 74 | 2018 |
Influence of CYP2B6 516G>T polymorphism and interoccasion variability (IOV) on the population pharmacokinetics of efavirenz in HIV-infected South African children M Viljoen, MO Karlsson, TM Meyers, H Gous, C Dandara, M Rheeders European journal of clinical pharmacology 68, 339-347, 2012 | 33 | 2012 |
Determination of salivary efavirenz by liquid chromatography coupled with tandem mass spectrometry A Theron, D Cromarty, M Rheeders, M Viljoen Journal of Chromatography B 878 (28), 2886-2890, 2010 | 29 | 2010 |
Efavirenz plasma concentrations at 1, 3, and 6 months post-antiretroviral therapy initiation in HIV type 1-infected South African children M Viljoen, H Gous, HS Kruger, A Riddick, TM Meyers, M Rheeders AIDS research and human retroviruses 26 (6), 613-619, 2010 | 20 | 2010 |
CYP2B6 Haplotype Predicts Efavirenz Plasma Concentration in Black South African HIV-1-Infected Children: A Longitudinal Pediatric Pharmacogenomic Study R Reay, C Dandara, M Viljoen, M Rheeders OMICS: A Journal of Integrative Biology 21 (8), 465-473, 2017 | 16 | 2017 |
Positive association between dietary iron intake and iron status in HIV-infected children in Johannesburg, South Africa HS Kruger, LJ Balk, M Viljoen, TM Meyers Nutrition Research 33 (1), 50-58, 2013 | 16 | 2013 |
Development and validation of high performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) method for determination of tenofovir in small volumes of human plasma M Mulubwa, M Rheeders, L Du Plessis, A Grobler, M Viljoen Journal of Chromatography & Separation Technique 6 (7), 2015 | 15 | 2015 |
Evidence for time-dependent interactions between ritonavir and lopinavir/ritonavir plasma levels following P-glycoprotein inhibition in Sprague-Dawley rats M Du Plooy, M Viljoen, M Rheeders Biological and Pharmaceutical Bulletin 34 (1), 66-70, 2011 | 14 | 2011 |
The effect of pinholes of different sizes on visual acuity under different refracting states and ambient lighting conditions N Abdul, N Meyer, M Van Bosch, A Van Zyl, M Viljoen, AS Carlson African Vision and Eye Health 68 (1), 38-48, 2009 | 11 | 2009 |
Hypertriglyceridaemia and the risk of pancreatitis six months post lopinavir/ritonavir initiation WP Greffrath, JM Du Plessis, M Viljoen, M Cockeran Southern African Journal of HIV Medicine 19 (1), 1-6, 2018 | 8 | 2018 |
Associations between plasma tenofovir concentration and renal function markers in HIV-infected women M Mulubwa, M Rheeders, C Fourie, M Viljoen Southern African Journal of HIV Medicine 17 (1), a458, 2016 | 8 | 2016 |
Critical appraisal of clinical guidelines for prevention and management of doxorubicin-induced cardiotoxicity I Moustafa, M Viljoen, VA Perumal-Pillay, F Oosthuizen Journal of Oncology Pharmacy Practice 29 (3), 695-708, 2023 | 4 | 2023 |
Vitamin E and levocarnitine as prophylaxis against doxorubicin-induced cardio toxicity in the adult cancer patient: a review I Moustafa, S Saka, M Viljoen, F Oosthuizen Journal of Oncology Pharmacy Practice 28 (6), 1388-1399, 2022 | 4 | 2022 |
Factors associated with bone mineral density and bone resorption markers in postmenopausal HIV-infected women on antiretroviral therapy: a prospective cohort study C Ellis, HS Kruger, M Viljoen, JA Dave, MC Kruger Nutrients 13 (6), 2090, 2021 | 4 | 2021 |
Retrospective clinical analysis of adverse drug reactions associated with antiretroviral therapy in Tlokwe district, South Africa R Van Graan, M Viljoen, M Rheeders, F Motara South African Family Practice 60 (1), 2018 | 4 | 2018 |
Parental reporting of adverse drug reactions in South Africa: An online survey S Pillay, M Mulubwa, M Viljoen African Journal of Primary Health Care & Family Medicine 13 (1), 2880, 2021 | 3 | 2021 |
Bone turnover markers in HIV-infected women on tenofovir-based antiretroviral therapy M Mulubwa, M Viljoen, IM Kruger, HS Kruger, M Rheeders AOSIS, 2017 | 3 | 2017 |
Lewenskwaliteit te midde van'n erge stressor:'n studie van bejaardes met Alzheimer se siekte of rumato๏ ede artritis PM Heyns, M Viljoen, DC Odendaal Health SA Gesondheid 9 (1), 47-56, 2004 | 3 | 2004 |
Fortologiese dimensies by bejaardes met Alzheimer se siekte of rumatoïde artritis M Viljoen University of the Free State, 2000 | 3 | 2000 |
A prospective study to evaluate the efficacy and safety of vitamin E and levocarnitine prophylaxis against doxorubicin-induced cardiotoxicity in adult breast cancer patients I Moustafa, C Connolly, M Anis, H Mustafa, F Oosthuizen, M Viljoen Journal of Oncology Pharmacy Practice 30 (2), 354-366, 2024 | 2 | 2024 |